CMAST to present at a Veeva seminar on modernizing quality management / April 10th, 2018 / Paris, France

 

CMAST, a fast-growing Belgian consultancy & project management company in life sciences, today announces that its Regulatory & Quality Expert Christof Peeters has been invited to give a keynote talk at a Veeva seminar on modernizing quality management. This event will take place on April 10th in Paris - France.

Veeva is a leader in cloud-based software for the global life sciences industry.


Since 2013, CMAST is a certified Veeva Technology Partner. As one of the first partners in Europe, CMAST developed in-depth knowledge in the domains of Submission, Clinical and Quality.


The Veeva Vault content management platform, which is specifically built for life sciences, has the unique capability to manage both content and data. CMAST can help implementing Veeva Vault across the board as the company has in-depth expertise in mapping and translating business processes, content migration, security, validation support, roll-out, governance & operational support.


More information on the Veeva seminar.

Note

CMAST is a fast-growing Belgian consultancy and project management company in life sciences.

With a team of more than 90 industry experts, CMAST provides support to pharma and life sciences companies, universities and research institutes. The company offers consultancy, project management and tangible business solutions in the following areas:

Early stage innovation services

Funding services

  • Project & Portfolio Management
  • R&D process optimization
  • Multi-stakeholder collaborations
  • Regulatory compliance & quality
  • Health data analytics & visualization
  • Supply chain


CMAST is headquartered in Temse (Belgium) and has branches in Switzerland, Germany, Poland and the US. Since 2018 CMAST is part of Modis Life Sciences, a subdivision of The Adecco Group, which gives the company a global reach.

For more info, please visit www.cmast.be.

 

 

Interested in a regular update of the Life Sciences and biotech sector in Flanders?